Decreased Insulin Regulated Aminopeptidase (IRAP) Levels in Gestational Diabetes Mellitus
NCT06716320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2024-12-04
Summary
This cohort study investigated whether IRAP levels could be a marker for predicting gestational diabetes mellitus. 80 women were included in the study, including the control group. The study duration was 12 months and the study was completed.
Conditions
- Gestational Diabetes Mellitus in Pregnancy
Sponsors & Collaborators
-
OSMAN KÖSE, MD
lead OTHER
Principal Investigators
-
Osman köse, ass. Prof. · Sakarya University Faculty of Medicine
Eligibility
- Min Age
- 21 Years
- Max Age
- 41 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-30
- Primary Completion
- 2022-01-30
- Completion
- 2022-04-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia
NCT06712550 ·Status: COMPLETED
-
C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese Pregnancies
NCT03650790 ·Status: COMPLETED ·Phase: NA
-
Insulin Resistance and Hypertensive Disorders in Pregnancy
NCT00412230 ·Status: COMPLETED
-
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
NCT06214702 ·Status: COMPLETED
-
Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
NCT06067685 ·Status: TERMINATED
-
Analyses of Interleukin-6, Presepsin and Pentraxin-3 in the Diagnosis and Severity of Late-onset Preeclampsia
NCT04126902 ·Status: COMPLETED
-
Evaluation of Serum Levels of C Reactive Protein (CRP) and Its Correlation With Fetal Ultrasound Parameters in the Prediction of Threatened Miscarriage in the First Trimester
NCT06011057 ·Status: COMPLETED
-
Maternal Serum Stathmin-1 Levels in Preeclampsia
NCT06481683 ·Status: TERMINATED
-
Kisspeptin Levels in Early Pregnancy
NCT04371991 ·Status: COMPLETED
-
Maternal Serum Pentraxin 3 in Early Pregnancy to Predict Gestational Diabetes Mellitus
NCT03563638 ·Status: COMPLETED
-
Maternal Serum Stathmin-1 Levels in Preeclampsia
NCT06623955 ·Status: COMPLETED
-
Adipokines, Inflammation, Insulin Resistance and Endothelial Dysfunction in Preeclampsia
NCT04455204 ·Status: COMPLETED
-
Random Urine Protein-creatinin Ratio to Predict Magnitude of Proteinuria
NCT01623791 ·Status: UNKNOWN
-
Thiol/Disulphide Homeostasis and Preeclampsia
NCT03927014 ·Status: COMPLETED
-
The Use of Early Pregnancy HbA1c in Predicting Excessive Fetal Growth in Women at Risk of Glucose Intolerance
NCT04858386 ·Status: TERMINATED
-
Prostasin Levels in Preeclamptic Women
NCT06623942 ·Status: COMPLETED
-
Serum Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in Early/Late-onset Preeclampsia
NCT03932877 ·Status: COMPLETED
-
Docosahexaenoic Acid Serum Levels in Patients With Preeclampsia
NCT05591638 ·Status: UNKNOWN
-
The Relationship Between Serum Gasdermin-D Levels and Pyroptosis and Preterm Labor
NCT05835700 ·Status: COMPLETED ·Phase: NA
-
Influence of TyG Index and TG/HDL-C Ratio on Fetal Macrosomia
NCT06463990 ·Status: COMPLETED
-
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
NCT03570632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Role of Liver and Visceral Fat in Glucose and Lipid Metabolism During Pregnancy
NCT02282475 ·Status: COMPLETED
-
Association Between Basal Proteinuria Levels and Pregnancy Outcomes in Familial Mediterranean Fever
NCT02092064 ·Status: UNKNOWN
-
sFlt-1:PlGF Ratio in Gestational Diabetes: PREDICTION (PREeclampsia in DIabetiC gestaTION) Study
NCT04877119 ·Status: UNKNOWN
-
Glycemic Control and Iron Status in Diabetic Pregnancies - a Study of New Markers
NCT03330951 ·Status: COMPLETED